Holen Sie sich die Stockscreener-App
4.325
2.15%
-0.095
Handel nachbörslich:
4.31
-0.015
-0.35%
Schlusskurs vom Vortag:
$4.42
Offen:
$4.35
24-Stunden-Volumen:
83,654
Relative Volume:
0.23
Marktkapitalisierung:
$123.86M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
-17.62%
1M Leistung:
+0.00%
6M Leistung:
+0.00%
1J Leistung:
+0.00%
1-Tages-Spanne:
$4.012
$4.3999
1-Wochen-Bereich:
$4.012
$5.395
52-Wochen-Spanne:
$4.012
$26.50
Turn Therapeutics Inc Stock (TTRX) Company Profile
Firmenname
Turn Therapeutics Inc
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie TTRX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TTRX
Turn Therapeutics Inc
|
4.325 | 123.86M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
421.67 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
628.00 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
423.47 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
831.48 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
182.77 | 39.72B | 447.02M | -1.18B | -868.57M | -6.1812 |
Turn Therapeutics Inc Aktie (TTRX) Neueste Nachrichten
TTRX News Today | Why did Turn Therapeutics stock go down today? - MarketBeat
Turn Therapeutics (TTRX) Stock Trends and Sentiment 2025 - MarketBeat
Turn Therapeutics (TTRX) Competitors and Alternatives 2025 - MarketBeat
Turn Therapeutics (TTRX) Stock Chart and Price History 2025 - MarketBeat
Turn Therapeutics signs license deal with surgical product supplier Medline - MSN
Turn Therapeutics partners with Medline for global supply agreement By Investing.com - Investing.com Australia
Turn Therapeutics Partners with Medline for Global Expansion - TipRanks
Turn Therapeutics Enters Global Supply, Development, and License Agreement with Leading Medical-Surgical Product Manufacturer and Distributor Medline - Yahoo Finance
Turn Therapeutics (TTRX) Stock Price, News & Analysis - MarketBeat
Turn Therapeutics (NASDAQ:TTRX) Insider Purchases $65,715.60 in Stock - Defense World
Turn Therapeutics appoints Kester to board of directors - MSN
Form 424B5 Turn Therapeutics Inc. - StreetInsider
What is the current Price Target and Forecast for Turn Therapeutics Inc. (TTRX) - Zacks Investment Research
Should I buy Turn Therapeutics Inc. (TTRX) - Zacks Investment Research
Insider Stock Purchases: October 24, 2025 - Quiver Quantitative
Strength Seen in Cartesian Therapeutics, Inc. (RNAC): Can Its 8.2% Jump Turn into More Strength? - MSN
Turn therapeutics officer Chaudhary buys $24,997 in shares By Investing.com - Investing.com Nigeria
Insider Buying: Arthur Golden Acquires 20,202 Shares of Turn The - GuruFocus
Turn Therapeutics director Golden buys $100k in shares - Investing.com
Turn therapeutics officer Chaudhary buys $24,997 in shares - Investing.com
Turn Therapeutics Updates Shareholders on Clinical Progress - TipRanks
Turn Therapeutics provides shareholder update on clinical program progress - TipRanks
Turn Therapeutics provides shareholder update highlighting continued execution across clinical and strategic milestones - MarketScreener
Turn Therapeutics Provides Shareholder Update on Clinical Progress and Capital Strategy - Quiver Quantitative
Turn Therapeutics Provides Shareholder Update Highlighting Continued Execution Across Clinical and Strategic Milestones - TradingView
Turn Therapeutics Provides Shareholder Update Highlighting Continued Execution Across Clinical ... - Bluefield Daily Telegraph
Can Karyopharm Therapeutics Inc. (25K0) stock ride next bull market cycle2025 Growth vs Value & Daily Market Momentum Tracking - nchmf.gov.vn
Turn Therapeutics launches webinar series for shareholder engagement - MSN
Will Serina Therapeutics Inc. stock beat value stocksJuly 2025 Rallies & Low Drawdown Trading Techniques - nchmf.gov.vn
Is Knight Therapeutics Inc. (04K) stock a good hedge against inflationWeekly Stock Recap & Fast Gain Swing Trade Alerts - nchmf.gov.vn
Turn Therapeutics Launches Webinar Series for Ongoing Shareholder Engagement, First Session October 22, 2025 - MarketScreener
Earnings Recap: Is Palvella Therapeutics Inc. (PI6) stock a contrarian opportunity2025 Key Lessons & Precise Buy Zone Tips - nchmf.gov.vn
Will Atossa Therapeutics Inc. (YAG2) stock outperform Dow JonesWeekly Risk Report & Consistent Profit Trade Alerts - nchmf.gov.vn
Biotech Firm Turn Therapeutics Goes Public - Los Angeles Business Journal
Will Advanced Proteome Therapeutics Corporation (0E81) stock gain from green policiesJuly 2025 Drop Watch & Smart Allocation Stock Tips - nchmf.gov.vn
Published on: 2025-10-19 02:06:54 - nchmf.gov.vn
Can Maze Therapeutics Inc. stock deliver sustainable ROEJuly 2025 Action & Real-Time Stock Price Movement Reports - nchmf.gov.vn
Layoff Watch: What risks investors should watch in AN2 Therapeutics Inc. stock2025 Top Decliners & Target Return Focused Picks - Trung tâm Dự báo KTTV quốc gia
Is Fulcrum Therapeutics Inc. stock a good choice for value investors2025 Trade Ideas & Weekly Chart Analysis and Trade Guides - nchmf.gov.vn
Is Zevra Therapeutics Inc. stock a smart buy before Fed meeting2025 Earnings Impact & Advanced Swing Trade Entry Alerts - nchmf.gov.vn
Stock Report: Will Mersana Therapeutics Inc. stock keep outperforming rivalsMarket Trend Summary & Safe Capital Growth Stock Tips - nchmf.gov.vn
Can CERo Therapeutics Holdings Inc. Equity Warrant stock surprise with earnings upsideJuly 2025 Summary & Safe Entry Point Identification - Trung tâm Dự báo KTTV quốc gia
Can Ernexa Therapeutics Inc. stock sustain market leadershipQuarterly Growth Report & Growth Focused Investment Plans - nchmf.gov.vn
Pullback Watch: Will Madrigal Pharmaceuticals Inc. stock benefit from upcoming earnings reports2025 Price Action Summary & AI Forecasted Entry/Exit Points - nchmf.gov.vn
Volatility Watch: Will Unicycive Therapeutics Inc. stock gain from lower inflationNew Guidance & Safe Entry Momentum Stock Tips - Trung tâm Dự báo KTTV quốc gia
Will Relay Therapeutics Inc. stock benefit from commodity prices2025 Buyback Activity & Fast Momentum Entry Tips - nchmf.gov.vn
Evaluating Pliant Therapeutics Inc. with trendline analysisJuly 2025 Decliners & Fast Entry Momentum Alerts - newser.com
Published on: 2025-10-18 11:14:04 - nchmf.gov.vn
Will TG Therapeutics Inc. stock reach all time highs in 2025Quarterly Profit Report & Safe Entry Trade Reports - nchmf.gov.vn
Best data tools to analyze Spyre Therapeutics Inc. stockQuarterly Trade Review & Consistent Income Trade Ideas - newser.com
Is Astria Therapeutics Inc. stock supported by strong fundamentalsChart Signals & Low Risk Entry Point Tips - Trung tâm Dự báo KTTV quốc gia
Finanzdaten der Turn Therapeutics Inc-Aktie (TTRX)
Es liegen keine Finanzdaten für Turn Therapeutics Inc (TTRX) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
Turn Therapeutics Inc-Aktie (TTRX) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Chaudhary Zuraiz | See Remarks |
Oct 23 '25 |
Buy |
4.95 |
5,050 |
24,998 |
5,050 |
| GOLDEN ARTHUR F | Director |
Oct 23 '25 |
Buy |
4.95 |
20,202 |
100,000 |
30,202 |
1.45%
0.86%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):